Hospital Pharmacy - February 2020 - 43

43

AbuAlsaud et al

5.
6.

7.
8.

9.

10.

11.

12.

13.

14.

15.

regulatory authorities. J Pharmacol Pharmacother. 2014;5(2):
88-92.
Kathleen A. Off-label use of drugs in children. Pediatrics.
2014;133(3):563-567.
Mukattash T, Wazaify M, Khuri-Boulos N, Jarab A, Hawwa
A, McElnay J. Perceptions and attitudes of Jordanian paediatricians towards off-label paediatric prescribing. Int J Clin
Pharm. 2011;33(6):964-973.
Pandolfini C, Bonati M. A literature review on off-label drug
use in children. Eur J Pediatr. 2005;164(9):552-558.
Balan S, Hassali M, Mak V. Awareness, knowledge and views
of off-label prescribing in children: a systematic review. Br J
Clin Pharmacol. 2015;80(6):1269-1280.
Gallelli L, Saullo F, Saullo E, et al. A questionnaire-based
study in Calabria on the knowledge of off-label drugs in pediatrics. J Pharmacol Pharmacother. 2013;4(5):S51-S54.
Langerová P, Vrtal J, Urbánek K. Incidence of unlicensed
and off-label prescription in children. Ital J Pediatr.
2014;40(1):12.
Gonçalves M, Heineck I. Frequency of prescriptions of offlabel drugs and drugs not approved for pediatric use in primary health care in a southern municipality of Brazil. Rev Paul
Pediatr. 2016;34(1):11-17.
Tefera Y, Gebresillassie B, Abebe T, et al. Off-label drug use
in hospitalized children: a prospective observational study at
Gondar University Referral Hospital, Northwestern Ethiopia.
Value Health. 2017;20(9):A519.
Mukattash TL, Hayajneh WA, Ibrahim SM, et al. Prevalence
and nature of off-label antibiotic prescribing for children in a
tertiary setting: a descriptive study from Jordan. Pharm Pract.
2016;14(3):725.
McLay JS. A prospective questionnaire assessment of attitudes
and experiences of off label prescribing among hospital based
paediatricians. Arch Dis Child. 2005;91(7):584-587.
Knopf H, Wolf I-K, Sarganas G, Zhuang W, Rascher W,
Neubert A. Off-label medicine use in children and adolescents:

16.

17.

18.

19.
20.
21.

22.

23.

24.

25.

26.

results of a population-based study in Germany. BMC Public
Health. 2013;13:631.
Wilkes M, Johns M. Informed consent and shared decisionmaking: a requirement to disclose to patients off-label prescriptions. PLoS Med. 2008;5(11):e223.
Bang V, Mallad A, Kannan S, Bavdekar S, Gogtay N, Thatte
UM. Awareness about and views of parents on the off-label
drug use in children. Int J Risk Saf Med. 2014;26(2):61-70.
Radley DC, Finkelstein SN, Stafford RS. Off-label prescribing among office-based physicians. Arch Intern Med.
2006;166(9):1021-1026.
Anderson G. Developmental pharmacokinetics. Semin Pediatr
Neurol. 2010;17(4):208-213.
Neville K, Becker M, Goldman J, Kearns G. Developmental
pharmacogenomics. Pediatr Anesth. 2011;21(3):255-265.
Mukattash T, Alzoubi K, Abuirjie A, et al. Perceptions and
attitudes towards off-label dispensing for pediatric patients, a
study of hospital based pharmacists in Jordan. Saudi Pharm J.
2018;26(1):20-24.
Ivanovska V, Rademaker C, van Dijk L, Mantel-Teeuwisse A.
Pediatric drug formulations: a review of challenges and progress. Pediatrics. 2014;134(2):361-372.
Gonçalves MG, Heineck I. Frequency of prescriptions of offlabel drugs and drugs not approved for pediatric use in primary
health care in a southern municipality of Brazil. Rev Paul
Pediatr. 2016;34(1):11-17.
Ekins-Daukes S, Helms PJ, Simpson CR, Taylor MW,
McLay JS. Off-label prescribing to children in primary care:
retrospective observational study. Eur J Clin Pharmacol.
2004;60(5):349-353.
't Jong GW, Eland IA, Sturkenboom MC, van den Anker JN,
Stricker BH. Unlicensed and off-label prescription of respiratory drugs to children. Eur Respir J. 2004;23(2):310-313.
Luedtke KE, Buck ML. Evaluation of off-label prescribing at
a children's rehabilitation center. J Pediatr Pharmacol Ther.
2014;19(4):296-301.
Hospital Pharmacy - February 2020

Table of Contents for the Digital Edition of Hospital Pharmacy - February 2020
